Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/96
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/95
End: -
Due: -
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer | NCT00022217 | Matrix Pharmaceutical | user2@example.com | None | 2000-11-30 | - | - | - | - | 2025-07-14 |
| Chemotherapy in Treating Patients With Liver Cancer | NCT00003044 | Matrix Pharmaceutical | user2@example.com | None | 1996-09-30 | - | - | - | - | 2025-07-14 |
| Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer | NCT00002659 | Matrix Pharmaceutical | user2@example.com | None | 1995-05-31 | - | - | - | - | 2025-07-14 |